ID

35936

Beschrijving

This is an exploratory study in Egypt that will combine a treatment trial among early course schizophrenia (ECSZ) patients with key analyses suggested by rodent studies. Specifically, the study will test the provocative results from animal studies indicating an impact of Toxoplasma Gondii (TOX) exposure on novelty seeking. The study will also test whether exposure to TOX is associated with other cognitive and behavioral changes, as well as changes in overall social function. We will also explore the relative efficacy of Sodium Valproate (Depakote, DEP) in improving clinical and overall social function among TOX exposed and unexposed patients. ODM derived from: https://clinicaltrials.gov/show/NCT02011750

Link

https://clinicaltrials.gov/show/NCT02011750

Trefwoorden

Versies (1)
  1. 04-04-19 04-04-19 -
Houder van rechten

University of Pittsburgh

Geüploaded op

4 april 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Valproate as Adjunctive Treatment for Toxoplasma Gondii Infection in Early Course Schizophrenia NCT02011750

Engels

Eligibility

1 Formulieren  
  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
Patient signed the written informed consent
Beschrijving

Informed consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
Patient is an adult man or woman (aged 18-50 years)
Beschrijving

Age and gender

Datatype

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
Patient with diagnosed schizophrenia or schizoaffective disorder (DSM IV)
Beschrijving

Diagnosis

Datatype

boolean

Alias
UMLS CUI [1,1]
C0011900
UMLS CUI [1,2]
C0036341
UMLS CUI [1,3]
C0220952
UMLS CUI [2,1]
C0011900
UMLS CUI [2,2]
C0036337
UMLS CUI [2,3]
C0220952
Patient is less than 5 years (since onset of psychosis) ill.
Beschrijving

Illness duration

Datatype

boolean

Alias
UMLS CUI [1,1]
C3176590
UMLS CUI [1,2]
C0033975
Patient is on a stable dose of an antipsychotic for at least a month
Beschrijving

Pharmaceutical treatment

Datatype

boolean

Alias
UMLS CUI [1,1]
C0040615
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
Patient scores 4 or more on at least one item of the positive and negative syndrome scale.
Beschrijving

PNNS-Scale

Datatype

boolean

Alias
UMLS CUI [1]
C0451383
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
Substance abuse in the past month/dependence past 6 months
Beschrijving

Substance abuse / dependence

Datatype

boolean

Alias
UMLS CUI [1,1]
C0038586
UMLS CUI [1,2]
C0332185
UMLS CUI [2,1]
C0038580
UMLS CUI [2,2]
C0262926
Patient with history of / or current medical/neurological illnesses e.g. mental retardation (DSM-IV) or epilepsy
Beschrijving

Neurological illnesses

Datatype

boolean

Alias
UMLS CUI [1]
C2186518
UMLS CUI [2,1]
C0027765
UMLS CUI [2,2]
C0521116
UMLS CUI [3]
C0025362
UMLS CUI [4]
C0014544
Patient with medical conditions that are judged by the consulting internist and research staff to be unstable
Beschrijving

Unstable medical conditions

Datatype

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0443343
Patient being pregnant or breast-feeding
Beschrijving

Pregnancy or breastfeeding

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Patient with known allergy or serious adverse event to DEP, received chlorpromazine, trimethoprim or DEP for up to 6 months prior to study entry.
Beschrijving

DEP = Depakote = Sodium Valproate

Datatype

boolean

Alias
UMLS CUI [1,1]
C0719751
UMLS CUI [1,2]
C0020517
UMLS CUI [2,1]
C0719751
UMLS CUI [2,2]
C1519255
UMLS CUI [3,1]
C0719751
UMLS CUI [3,2]
C2826667
UMLS CUI [4,1]
C0008286
UMLS CUI [4,2]
C2826667
UMLS CUI [5,1]
C0041041
UMLS CUI [5,2]
C2826667
Terug naar het begin van de pagina

Similar models

Eligibility

1 Formulieren
  1. StudyEvent: Eligibility
    1. Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Informed consent
Item
Patient signed the written informed consent
boolean
C0021430 (UMLS CUI [1])
Age and gender
Item
Patient is an adult man or woman (aged 18-50 years)
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Diagnosis
Item
Patient with diagnosed schizophrenia or schizoaffective disorder (DSM IV)
boolean
C0011900 (UMLS CUI [1,1])
C0036341 (UMLS CUI [1,2])
C0220952 (UMLS CUI [1,3])
C0011900 (UMLS CUI [2,1])
C0036337 (UMLS CUI [2,2])
C0220952 (UMLS CUI [2,3])
Illness duration
Item
Patient is less than 5 years (since onset of psychosis) ill.
boolean
C3176590 (UMLS CUI [1,1])
C0033975 (UMLS CUI [1,2])
Pharmaceutical treatment
Item
Patient is on a stable dose of an antipsychotic for at least a month
boolean
C0040615 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
PNNS-Scale
Item
Patient scores 4 or more on at least one item of the positive and negative syndrome scale.
boolean
C0451383 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Substance abuse / dependence
Item
Substance abuse in the past month/dependence past 6 months
boolean
C0038586 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C0038580 (UMLS CUI [2,1])
C0262926 (UMLS CUI [2,2])
Neurological illnesses
Item
Patient with history of / or current medical/neurological illnesses e.g. mental retardation (DSM-IV) or epilepsy
boolean
C2186518 (UMLS CUI [1])
C0027765 (UMLS CUI [2,1])
C0521116 (UMLS CUI [2,2])
C0025362 (UMLS CUI [3])
C0014544 (UMLS CUI [4])
Unstable medical conditions
Item
Patient with medical conditions that are judged by the consulting internist and research staff to be unstable
boolean
C3843040 (UMLS CUI [1,1])
C0443343 (UMLS CUI [1,2])
Pregnancy or breastfeeding
Item
Patient being pregnant or breast-feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Contraindication to DEP
Item
Patient with known allergy or serious adverse event to DEP, received chlorpromazine, trimethoprim or DEP for up to 6 months prior to study entry.
boolean
C0719751 (UMLS CUI [1,1])
C0020517 (UMLS CUI [1,2])
C0719751 (UMLS CUI [2,1])
C1519255 (UMLS CUI [2,2])
C0719751 (UMLS CUI [3,1])
C2826667 (UMLS CUI [3,2])
C0008286 (UMLS CUI [4,1])
C2826667 (UMLS CUI [4,2])
C0041041 (UMLS CUI [5,1])
C2826667 (UMLS CUI [5,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial